Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9 Suppl 2
|
| pubmed:dateCreated |
1993-2-25
|
| pubmed:abstractText |
The causes of ulcerative colitis are still unknown and above all the circumstances which can lead to inflammatory episodes are unclear. Antibiotic therapy has not provided encouraging results so far but it is possible that the pathogenesis of this disease may involve bacterial species which have not yet been identified. The use of an antibiotic with specific colic activity therefore seems to be justified.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0392-0623
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2-3
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading |
pubmed-meshheading:1486196-Colitis, Ulcerative,
pubmed-meshheading:1486196-Colon,
pubmed-meshheading:1486196-Humans,
pubmed-meshheading:1486196-Metronidazole,
pubmed-meshheading:1486196-N-Formylmethionine Leucyl-Phenylalanine,
pubmed-meshheading:1486196-Tobramycin,
pubmed-meshheading:1486196-Vancomycin
|
| pubmed:articleTitle |
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis.
|
| pubmed:affiliation |
Istituto di Clinica Medica e Gastroenterologia, S. Orsola, Bologna, Italy.
|
| pubmed:publicationType |
Journal Article,
Review
|